Nanoparticulate and Hydrogel Vehicles for Stimuli-Responsive and Sustained Controlled Release of Active Pharmaceutical Ingredients
Pharmaceuticals · 21.08.2026 · 19 (8) · 1324
DOI: 10.3390/ph19081324 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 21.08.2026. Verfasst von Simona Ardelean und 14 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Vasile Goldiș Western University of Arad, 86 L. Rebreanu St., 310414 Arad, Romania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Most active pharmaceutical ingredients (APIs) reach their target by passive systemic distribution, so the dose required for efficacy at the lesion is set by what healthy tissue can tolerate; conventional dosage forms consequently produce pharmacokinetic profiles that oscillate between toxic peaks and sub-therapeutic troughs. Nanoparticulate carriers (liposomes, lipid nanoparticles, polymeric and inorganic systems, and biomimetic carriers) and hydrogels (natural, synthetic, supramolecular, and microgel-assembled) have emerged as the dominant strategies to address this, increasingly combined as hybrid nanoparticle–hydrogel constructs in which the gel provides locoregional retention and the nanoparticles provide cargo protection, intracellular delivery and stimuli responsiveness. Stimuli-responsive chemistries (pH, redox, enzyme, ROS, hypoxia, temperature, light, magnetic, ultrasound, glucose, and multi-stimuli logic) translate the molecular signatures of a disease into spatiotemporally controlled cargo release. This narrative review consolidates the state of the art (prioritizing 2022–2026) and departs from the conventional carrier-type survey in one respect: the literature is read along an explicit chain—disease cue, sensing chemistry, carrier architecture, release mechanism and kinetics, administration route, and clinical readiness—which exposes a variable that classification by carrier type conceals. Across all three material classes, what governs release behavior is not primarily the carrier chemistry but the identity of the released species (dissolved drug, drug from an embedded nanoparticle, an intact nanoparticle, and a matrix fragment) and the transport step that limits it. This is why power-law exponent analysis developed for dissolved drug fits particulate release poorly, why statistical goodness-of-fit cannot by itself establish a release mechanism, and why carrier class predicts clinical readiness less well than administration route and regulatory product type. Translational hurdles—CMC complexity, regulatory fragmentation, anti-PEG immunogenicity, and the structural mismatch between preclinical promise and clinical efficacy—are critically appraised in light of previously reported
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Pharmacy, Vasile Goldiș Western University of Arad, 86 L. Rebreanu St., 310414 Arad, Romania.
- Multidisciplinary Doctoral School, Vasile Goldiș Western University of Arad, 86 L. Rebreanu St., 310414 Arad, Romania.
- Department of Analytical Chemistry, Faculty of Pharmacy, "Victor Babeș" University of Medicine and Pharmacy Timișoara, Eftimie Murgu Square No. 2, 300041 Timișoara, Romania.
- Advanced Instrumental Screening Center, Faculty of Pharmacy, "Victor Babeş" University of Medicine and Pharmacy Timișoara, Eftimie Murgu Square No. 2, 300041 Timișoara, Romania.
- Department V (Internal Medicine I), Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy Timișoara, 12 Revoluției din 1989 Blvd., 300041 Timișoara, Romania.
- Faculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.
ORCID-Profile: Oana Koppandi, Adriana Ledeți, Livia C Borcan, George A Drăghici, Paul Albu
Zitieren
APA
Ardelean, S., Ciopănoiu, I., Cuc-Hepcal, I., Samoila, A. O. J., Morodan, C., Borlea, M., Constantinescu, S. L., Koppandi, O., Ciurlea, S., Tomoroga, C., Ledeți, A., Borcan, L. C., Drăghici, G. A., Albu, P., & Dehelean, C. A. (2026). Nanoparticulate and Hydrogel Vehicles for Stimuli-Responsive and Sustained Controlled Release of Active Pharmaceutical Ingredients. Pharmaceuticals, 19(8), 1324. https://doi.org/10.3390/ph19081324
Vancouver
Ardelean S, Ciopănoiu I, Cuc-Hepcal I, Samoila AOJ, Morodan C, Borlea M, et al. Nanoparticulate and Hydrogel Vehicles for Stimuli-Responsive and Sustained Controlled Release of Active Pharmaceutical Ingredients. Pharmaceuticals. 2026;19(8):1324. doi:10.3390/ph19081324
BibTeX
@article{Ardelean2026,
author = {Ardelean, Simona and Ciopănoiu, Ioana and Cuc-Hepcal, Ioana and Samoila, Anda O J and Morodan, Corina and Borlea, Mihaela and Constantinescu, Silviu L and Koppandi, Oana and Ciurlea, Sorina and Tomoroga, Carmen and Ledeți, Adriana and Borcan, Livia C and Drăghici, George A and Albu, Paul and Dehelean, Cristina A},
title = {Nanoparticulate and Hydrogel Vehicles for Stimuli-Responsive and Sustained Controlled Release of Active Pharmaceutical Ingredients},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {8},
pages = {1324},
doi = {10.3390/ph19081324}
}
EUVIMED